Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib (Q35230406)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib |
scientific article |
Statements
1 reference
Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib (English)
1 reference
E Jason Abel
1 reference
Stephen H Culp
1 reference
Nizar M Tannir
1 reference
Pheroze Tamboli
1 reference
Surena F Matin
1 reference
Christopher G Wood
1 reference
14 July 2011
1 reference
1 reference
60
1 reference
6
1 reference
1273-1279
1 reference
Identifiers
1 reference
1 reference
1 reference